Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.37 +0.51 (+1.77%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Net Income towards Common Stockholders (2014 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) posted Net Income towards Common Stockholders of $2.45 million for the quarter ended Jun 30, 2026, compared with -$119.64 million a year earlier and down 85.6% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Income towards Common Stockholders at Lakefront Biotherapeutics was $373.84 billion, up 374.4% year-over-year; for the year ended Dec 31, 2025, it came in at $362.54 million, up 352.1% from the prior year.

  • In prior years, Lakefront Biotherapeutics' Net Income towards Common Stockholders was $80.18 million in the year ended Dec 31, 2024 (-64.8%), $227.77 million in the year ended Dec 31, 2023, -$229.75 million in the year ended Dec 31, 2022 and -$122.16 million in the year ended Dec 31, 2021.
  • Quarterly Net Income towards Common Stockholders has run from a low of -$236.34 million in the quarter ended Sep 30, 2025 to a high of $374.06 billion in the quarter ended Dec 31, 2025 over five years.
  • According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was $16.97 million (quarter ended Mar 31, 2026), $374.06 billion (quarter ended Dec 31, 2025) and -$236.34 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.61 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -248.00 Mn
10 Lakefront Biotherapeutics 1.94 Bn 1.94 Bn 3.51 Mn 2.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.45 Mn
Mar 31, 2026 16.97 Mn
Dec 31, 2025 374.06 Bn
Sep 30, 2025 -236.34 Mn
Jun 30, 2025 -119.64 Mn
Mar 31, 2025 -161.36 Mn
Dec 31, 2024 79.11 Bn
Sep 30, 2024 -24.45 Mn
Jun 30, 2024 -20.65 Mn
Mar 31, 2024 98.01 Mn
Dec 31, 2023 227.72 Bn
Sep 30, 2023 28.09 Mn
Jun 30, 2023 5.55 Mn
Mar 31, 2023 24.91 Mn
Dec 31, 2022 -211.40 Mn
Sep 30, 2022 21.69 Mn
Jun 30, 2022 -20.30 Mn
Mar 31, 2022 -14.94 Mn
Dec 31, 2021 18.73 Mn
Sep 30, 2021 -141.04 Mn
API Access

Lakefront Biotherapeutics Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=LKFT&period=max&api_key=YOUR_API_KEY